← Back to Search

Healthy Controls for Benign Prostatic Hyperplasia

N/A
Recruiting
Led By Alejandro Roldan-Alzate, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up research visit 1 day
Awards & highlights

Study Summary

The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI)-UDS evaluation. Both US and MRI are non-invasive imaging techniques, but US is a more cost-effective and widely available technology. 80 participants will be enrolled and will be on study for up to 2.5 hours (1.5 hour MRI and 1 hour US).

Eligible Conditions
  • Benign Prostatic Hyperplasia
  • Lower Urinary Tract Symptoms

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~research visit 1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and research visit 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bladder contractility index (BOI)
Bladder outlet obstruction index (BOOI)
International Prostate Symptom Score (IPSS)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Known BPH/LUTSExperimental Treatment1 Intervention
Adult men diagnosed with BPH/LUTS
Group II: Healthy ControlsExperimental Treatment1 Intervention
Age-matched healthy men with no lower urinary tract symptoms

Find a Location

Who is running the clinical trial?

Wisconsin Partnership ProgramOTHER
7 Previous Clinical Trials
378 Total Patients Enrolled
University of Wisconsin, MadisonLead Sponsor
1,186 Previous Clinical Trials
3,169,367 Total Patients Enrolled
Alejandro Roldan-Alzate, PhDPrincipal InvestigatorUW Department of Mechanical Engineering and Radiology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~53 spots leftby Jan 2026